Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium

O Cabral-Marques, G Moll, R Catar, B Preuß… - Autoimmunity …, 2023 - Elsevier
G protein-coupled receptors (GPCR) are involved in various physiological and
pathophysiological processes. Functional autoantibodies targeting GPCRs have been …

[HTML][HTML] Chronic Active T-Cell Mediated Kidney Rejection as a Clinically Significant Type of Allograft Loss?

J Mizera, J Pilch, D Kamińska, M Krajewska, P Donizy… - Diagnostics, 2022 - mdpi.com
The purpose of this article is to assess the present knowledge about chronic active (CA) T-
cell mediated rejection (TCMR) of a kidney. In the research authors review current Banff …

[HTML][HTML] Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from …

A Philippe, W Arns, V Ditt, IA Hauser… - Frontiers in …, 2023 - frontiersin.org
Background Non-human leukocyte antigen (non-HLA) antibodies including antibodies
targeting Angiotensin II type 1 (AT1R) and Endothelin-1 type A (ETAR) receptors represent a …

[HTML][HTML] Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk …

D Sikorska, D Kamińska, R Catar, D Wu… - Journal of Clinical …, 2023 - mdpi.com
Early identification of allograft vasculopathy and the concomitant elimination of adverse risk
factors is essential for improving the long-term prognosis of heart transplant (HTx) recipients …

[HTML][HTML] Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR …

G Moll, C Luecht, MA Gyamfi, DLM da Fonseca… - Frontiers in …, 2023 - frontiersin.org
Non-HLA-directed regulatory autoantibodies (RABs) are known to target G-protein coupled
receptors (GPCRs) and thereby contribute to kidney transplant vasculopathy and failure …

[HTML][HTML] Antigen and cell-based assays for the detection of non-HLA antibodies

RGM Lammerts, D Altulea, BG Hepkema… - Frontiers in …, 2022 - frontiersin.org
To date, human leukocyte antigens (HLA) have been the major focus in the approach to
acute and chronic antibody-mediated rejection (AMBR) in solid-organ transplantation …

同种异体复合组织移植Banff 移植病理学诊断标准及进展.

熊艳, 叶啟发, 孔凡华, 郭晖 - Organ Transplantation/Qi …, 2022 - search.ebscohost.com
同种异体复合组织移植(CTA) 是一门新兴的用于治疗功能性组织或肢体缺损的移植学科,
由于绝大多数CTA 移植物为带血管的移植物, 因此也称为带血管的复合组织移植(VCA) …

[PDF][PDF] Aurélie Philippe1, 2*, Wolfgang Arns3, Vanessa Ditt4, Ingeborg A. Hauser5, Friedrich Thaiss6, Claudia Sommerer7, Barbara Suwelack8, Duska Dragun1, 2 …

A Philippe, W Arns, V Ditt, IA Hauser, F Thaiss… - 2023 - researchgate.net
Background: Non-human leukocyte antigen (non-HLA) antibodies including antibodies
targeting Angiotensin II type 1 (AT1R) and Endothelin-1 type A (ETAR) receptors represent a …

[引用][C] Kami nska, D

J Mizera, J Pilch - Krajewska, M - europepmc.org
The purpose of this article is to assess the present knowledge about chronic active (CA) T-
cell mediated rejection (TCMR) of a kidney. In the research authors review current Banff …